Dyadic (AMEX:DIL)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more Dyadic Charts. Click Here for more Dyadic Charts.](/p.php?pid=staticchart&s=A%5EDIL&p=8&t=15)
Dyadic International, Inc. (AMEX:DIL), a biotechnology
company, announced today that it is scheduled to join the new Russell
Microcap(TM) Index when the Russell Investment Group reconstitutes its
family of U.S. indexes on June 24. Russell recently posted a
preliminary membership list at
http://www.russell.com/us/indexes/us/reconstitution/microcap_adds.asp.
The Russell Microcap Index will be comprised of the smallest 1,000
securities in the small-cap Russell 2000(R) Index plus the next 1,000
companies, based on a ranking of all U.S. equities by market
capitalization and will not include less-regulated OTC bulletin board
securities or pink-sheet stocks priced under $1. This new index offers
managers and other investors a comprehensive, unbiased barometer to
compare their performance against the genuine microcap marketplace of
stocks.
"We're pleased to be named to the Russell Microcap Index," said
Mark Emalfarb, Dyadic's Chief Executive Officer. "This will increase
Dyadic's visibility with investors and institutions that rely on the
Russell Indexes as a key part of their investment strategy."
The Russell indexes are widely used by investment managers and
institutional investors for index funds and as benchmarks for both
passive and active investment strategies. More than $2.5 trillion in
assets currently are benchmarked to them. Investment managers who
oversee these funds purchase shares of member stocks according to that
company's weighting in the particular index.
Companies slated for the Russell Microcap were ranked as of May
31, 2005, by total market capitalization and weighted based on
free-float adjustment, an integral aspect of Russell index
methodology. Free-float adjustment means stocks are weighted by their
available market capitalization which is calculated by multiplying the
primary closing price by the available shares.
About Dyadic:
Dyadic International, Inc., is engaged in the development,
manufacture and sale of biological products (proteins, enzymes,
peptides and other bio-molecules), as well as the licensing of its
enabling proprietary technology to business collaborators for the
discovery, development and manufacture of biological products from
genes. Dyadic markets its products and services for applications in
the textile, chemical, agricultural, pulp & paper, pharmaceutical,
biotechnology and other industries, using its proprietary C1 Host
Technology and C1 Expression and Screening Systems for the discovery,
development and production of biological products.
About the Russell Indexes:
The information presented above about the Russell indexes and the
Russell Microcap Index is derived from the Russell Investment Group
website, http://www.russell.com.
Cautionary Statement for Forward-Looking Statements
Statements contained in this press release may contain information
that includes or is based upon certain "forward-looking statements"
relating to our business. For a discussion of the factors that could
cause actual results to vary from these forward-looking statements,
please see our filings from time to time with the Securities and
Exchange Commission, which are available free of charge on the SEC's
web site at http://www.sec.gov, including our Annual Report on Form
10-KSB for the year ended December 31, 2004, which was filed with the
SEC on April 15, 2005, and our Quarterly Report on Form 10-QSB, which
was filed on May 17, 2005. We expressly disclaim any intent or
obligation to update any forward-looking statements.